DeepMed Research

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Sleep TO Prevent Post-surgical Pain

Not Applicable

Not yet recruiting

Conditions: Knee Osteoarthristis

First Posted Date: 2025-05-16

Last Posted Date: 2025-05-16

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 252

Registration Number: NCT06976138

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
🇺🇸
Mass General Brigham, Chestnut Hill, Massachusetts, United States

The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients

Not Applicable

Recruiting

Conditions: Glaucoma

First Posted Date: 2025-05-14

Last Posted Date: 2025-05-14

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 40

Registration Number: NCT06971588

Locations: 🇺🇸
Wilmer Eye Institute, Bethesda, Maryland, United States

Cardiometabolic Disease Risk Factors in Cameroon

Not yet recruiting

Conditions: Cardiac Disease
Metabolic Disease

First Posted Date: 2025-05-04

Last Posted Date: 2025-05-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 200

Registration Number: NCT06957548

Locations: 🇨🇲
Newbell Protestant Hospital, Douala, Littoral, Cameroon

Resilience Among Individuals With Opioid Use Disorder

Not Applicable

Not yet recruiting

Conditions: Opioid Use Disorder

First Posted Date: 2025-05-01

Last Posted Date: 2025-05-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 125

Registration Number: NCT06954402

Locations: 🇺🇸
Johns Hopkins University Bayview Medical Campus, Baltimore, Maryland, United States

Relationship Between Anesthetic Regimen and Bone Cement Implantation Syndrome (BCIS)

Not Applicable

Conditions: Bone Cement Implantation Syndrome

First Posted Date: 2025-04-30

Last Posted Date: 2025-05-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 24

Registration Number: NCT06952257

Locations: 🇺🇸
Dept of Orthopadic Surgery, Johns Hopkins Hospital, JHOC 5221, 601 N. Caroline St., Baltimore, Maryland, United States

Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

Phase 2

Not yet recruiting

Conditions: Food Hypersensitivity

Interventions: Drug: Omalizumab

First Posted Date: 2025-04-18

Last Posted Date: 2025-05-21

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 32

Registration Number: NCT06934200

Locations: 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States

Leveraging Electronic Health Record Tools to Improve the Evidence-Based Treatment of Children Hospitalized With Bronchiolitis

Not Applicable

Recruiting

Conditions: Bronchiolitis

First Posted Date: 2025-04-17

Last Posted Date: 2025-05-08

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 800

Registration Number: NCT06932341

Locations: 🇺🇸
Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States
🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Children's Center, Baltimore, Maryland, United States

HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

Not Applicable

Not yet recruiting

Conditions: Alzheimer Disease
Dementia
Hearing Loss
Cognitive Impairment

First Posted Date: 2025-04-16

Last Posted Date: 2025-04-29

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 300

Registration Number: NCT06930560

Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes

Not Applicable

Recruiting

Conditions: Hypertension
Type 2 Diabetes Mellitus (T2DM)

First Posted Date: 2025-04-10

Last Posted Date: 2025-05-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 80

Registration Number: NCT06921356

Locations: 🇺🇸
Johns Hopkins ProHealth Clinical Research Unit, Baltimore, Maryland, United States

Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults

Phase 2

Recruiting

Conditions: Hippocampal Overactivity
Dementia

Interventions: Drug: AGB101
Drug: Placebo

First Posted Date: 2025-04-09

Last Posted Date: 2025-04-27

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 60

Registration Number: NCT06919926

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy